Biscayne Pharmaceuticals Inc. — Form D
Biscayne Pharmaceuticals Inc. of MIAMI, FL, a company, filed a Form D exempt-offering notice with the SEC on 2015-11-04. The offering totals $2.0M, of which $609K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-11-04
- Form: D
- Accession: 0001448051-15-000014
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $609K
- Remaining: $1.4M
- Investors: 3
- Date of first sale: 2015-10-23
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-250669
Issuer
- Name: Biscayne Pharmaceuticals Inc.
- CIK: 0001567845
- Entity type: Corporation
- Jurisdiction: FLORIDA
- Incorporated: 2012
- Address: 4770 BISCAYNE BLVD., SUITE 660, MIAMI, FL, 33137
- Phone: 305-505-0974
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Norman J Block | Director | Miami, FL |
| Warren J Lammert | Director | Miami, FL |
| Jack J Levine | Director | Scottsdale, AZ |
| SAMUEL J REICH | Director | MIAMI BEACH, FL |
| Stephen D Collins | Executive Officer | Lake Forest, IL |
| SAMUEL J REICH | Executive Officer | MIAMI BEACH, FL |
| Peter J Goldstein | Executive Officer | Rye, NY |
| Nair J Laxmi | Executive Officer | Miami, FL |
| Jared J Mendel | Executive Officer | Miami, FL |
Other filings by this issuer (2)
More